斯鲁利单抗联合化疗一线治疗PD-L1（CPS≥1）局部晚期或转移性食管鳞状细胞癌的成本-效用分析
赵荧荧, 居文祥, 张小涵, 路萝兰, 沈爱宗
Cost-utility analysis of serplulimab combined with chemotherapy in the first-line treatment of PD-L1 （CPS≥1） locally advanced or metastatic esophageal squamous cell carcinoma
ZHAO Yingying, JU Wenxiang, ZHANG Xiaohan, LU Luolan, SHEN Aizong
中国医院药学杂志
.
2024, (3): 298
-304
.
DOI: 10.13286/j.1001-5213.2024.03.08
